申请人:Boehringer Ingelheim International GmbH
公开号:US07569561B2
公开(公告)日:2009-08-04
The present invention encompasses compounds of general formula (1)
wherein
R1 to R6, X and Y are defined as in claim 1, which are suitable for the treatment of diseases characterised by excessive or anomalous cell proliferation, as well as the use thereof for preparing a pharmaceutical composition with the above-mentioned properties.
本发明涵盖了一般式(1)的化合物,其中R1到R6,X和Y如权利要求1中所定义,适用于治疗由过度或异常细胞增殖所表征的疾病,以及用于制备具有上述特性的制药组合物的用途。